Brainsway (BWAY) Total Current Liabilities (2018 - 2025)
Brainsway (BWAY) posted quarterly Total Current Liabilities of $22.5 million for Q4 2025, up 46.59% year-on-year from $15.3 million in Q4 2024, and down 11.81% on a QoQ basis from $25.5 million in Q2 2025.
Brainsway (BWAY) Total Current Liabilities (2018 - 2025) Analysis & Trends
Brainsway (BWAY) has reported Total Current Liabilities for 8 consecutive years, with $22.5 million the latest figure, recorded in Q4 2025.
- Quarterly Total Current Liabilities rose 46.59% year-over-year to $22.5 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $22.5 million (up 46.59% YoY) and the FY2025 annual result came in at $22.5 million, up 46.59% from the prior year.
- Total Current Liabilities retreated to $22.5 million in Q4 2025 per BWAY's latest filing, from $25.5 million in the prior quarter.
- Over the last five years, Total Current Liabilities for BWAY reached as high as $25.5 million in Q2 2025 and fell as low as $6.9 million in Q1 2021.
- A 5-year average of $12.4 million and a median of $9.1 million in 2021 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities slipped 10.21% — and 2024, when it soared 57.22%.
- Year by year, Total Current Liabilities stood at $9.1 million in 2021, then decreased by 10.21% to $8.1 million in 2022, then grew by 19.9% to $9.8 million in 2023, then soared by 57.22% to $15.3 million in 2024, then soared by 46.59% to $22.5 million in 2025.
- According to Business Quant data, Total Current Liabilities over the past three periods registered $22.5 million, $25.5 million, and $15.3 million for Q4 2025, Q2 2025, and Q4 2024 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 18.38 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 6.32 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 11.66 Bn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | 4.57 Bn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 1.41 Bn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 2.22 Bn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 8.70 Bn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 8.53 Bn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 1.60 Bn |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 22.50 Mn |
| Jun 30, 2025 | 25.51 Mn |
| Dec 31, 2024 | 15.35 Mn |
| Dec 31, 2023 | 9.76 Mn |
| Dec 31, 2022 | 8.14 Mn |
| Dec 31, 2021 | 9.07 Mn |
| Sep 30, 2021 | 7.75 Mn |
| Jun 30, 2021 | 7.01 Mn |
| Mar 31, 2021 | 6.86 Mn |
| Dec 31, 2020 | 6.80 Mn |
| Sep 30, 2020 | 6.97 Mn |
| Dec 31, 2019 | 6.72 Mn |
| Sep 30, 2019 | 6.72 Mn |
| Dec 31, 2018 | 8.34 Mn |